KR20230121960A - 테르페노페놀 화합물 및 이의 용도 - Google Patents
테르페노페놀 화합물 및 이의 용도 Download PDFInfo
- Publication number
- KR20230121960A KR20230121960A KR1020227037909A KR20227037909A KR20230121960A KR 20230121960 A KR20230121960 A KR 20230121960A KR 1020227037909 A KR1020227037909 A KR 1020227037909A KR 20227037909 A KR20227037909 A KR 20227037909A KR 20230121960 A KR20230121960 A KR 20230121960A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- cbd
- pet
- diol
- prop
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/32—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions without formation of -OH groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/38—Alcohols containing six-membered aromatic rings and other rings and having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/001—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain
- C07C37/003—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain by hydrogenation of an unsaturated part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
- C07C37/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by addition reactions, i.e. reactions involving at least one carbon-to-carbon unsaturated bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003270P | 2020-03-31 | 2020-03-31 | |
| US63/003,270 | 2020-03-31 | ||
| PCT/GB2021/050812 WO2021198692A1 (en) | 2020-03-31 | 2021-03-31 | Terpenophenolic compounds and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20230121960A true KR20230121960A (ko) | 2023-08-22 |
Family
ID=75426633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020227037909A Pending KR20230121960A (ko) | 2020-03-31 | 2021-03-31 | 테르페노페놀 화합물 및 이의 용도 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12552733B2 (https=) |
| EP (1) | EP4126800A1 (https=) |
| JP (1) | JP7714571B2 (https=) |
| KR (1) | KR20230121960A (https=) |
| CN (1) | CN116194431B (https=) |
| AU (1) | AU2021248627A1 (https=) |
| BR (1) | BR112022019616A2 (https=) |
| CA (1) | CA3177186A1 (https=) |
| GB (2) | GB2609814B (https=) |
| IL (1) | IL296861A (https=) |
| MX (1) | MX2022011832A (https=) |
| WO (1) | WO2021198692A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3179235A1 (en) * | 2019-05-23 | 2020-11-26 | Kare Chemical Technologies Inc. | Catalytic cannabinoid processes and precursors |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL136839A (en) * | 2000-06-16 | 2006-12-10 | Yissum Res Dev Co | Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same |
| CA2623723A1 (en) | 2005-09-29 | 2007-04-12 | Amr Technology, Inc. | Process for production of delta-9-tetrahydrocannabinol |
| DK2176208T3 (en) * | 2007-07-30 | 2015-04-27 | Zynerba Pharmaceuticals Inc | Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof |
| DE102009019322A1 (de) * | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Verfahren zur Herstellung von Synthetischen Cannabinoiden |
| TWI583374B (zh) * | 2010-03-30 | 2017-05-21 | Ｇｗ伐瑪有限公司 | 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途 |
| WO2014177593A1 (en) | 2013-04-29 | 2014-11-06 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Amorfrutin analogs as ppargamma-modulators |
| US9526706B1 (en) | 2015-06-16 | 2016-12-27 | Hong Kong Baptist University | Method of using dihydro-resveratrol for treating acute pancreatitis and associated pulmonary injury |
| US9738581B2 (en) * | 2015-06-16 | 2017-08-22 | Hong Kong Baptist University | Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions |
| US10059683B2 (en) | 2015-07-10 | 2018-08-28 | Noramco, Inc. | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol |
| AU2017250303B2 (en) | 2016-04-15 | 2019-09-26 | Teewinot Technologies Limited | Biosynthesis of cannabinoid prodrugs |
| JP2019523228A (ja) | 2016-06-16 | 2019-08-22 | ティーウィノット テクノロジーズ リミテッド | カンナビノイドプロドラッグの製造のための方法、薬学的製剤、およびその使用 |
| US10640482B2 (en) | 2017-07-21 | 2020-05-05 | University Of South Florida | Synthesis of cannabinoids |
| SG11202001725SA (en) * | 2017-09-01 | 2020-03-30 | Pureform Global Inc | Synthetic cannabidiol compositions and methods of making the same |
| JP2021535203A (ja) * | 2018-08-20 | 2021-12-16 | ベッソール ファルマ、エルエルシー | 既知および新規カンナビノイドの適用 |
| CA3179235A1 (en) * | 2019-05-23 | 2020-11-26 | Kare Chemical Technologies Inc. | Catalytic cannabinoid processes and precursors |
| AU2020345656A1 (en) * | 2019-09-09 | 2022-04-21 | Kare Chemical Technologies Inc. | Cannabinoid derivatives, precursors and uses |
| WO2021046640A1 (en) * | 2019-09-10 | 2021-03-18 | Kare Chemical Technologies Inc. | Cannabinoid derivatives and precursors, and asymmetric synthesis for same |
-
2021
- 2021-03-31 BR BR112022019616A patent/BR112022019616A2/pt unknown
- 2021-03-31 GB GB2215746.5A patent/GB2609814B/en active Active
- 2021-03-31 MX MX2022011832A patent/MX2022011832A/es unknown
- 2021-03-31 US US17/916,494 patent/US12552733B2/en active Active
- 2021-03-31 KR KR1020227037909A patent/KR20230121960A/ko active Pending
- 2021-03-31 JP JP2022560311A patent/JP7714571B2/ja active Active
- 2021-03-31 GB GB2104690.9A patent/GB2595355A/en not_active Withdrawn
- 2021-03-31 AU AU2021248627A patent/AU2021248627A1/en active Pending
- 2021-03-31 EP EP21717177.6A patent/EP4126800A1/en active Pending
- 2021-03-31 WO PCT/GB2021/050812 patent/WO2021198692A1/en not_active Ceased
- 2021-03-31 CN CN202180038597.7A patent/CN116194431B/zh active Active
- 2021-03-31 IL IL296861A patent/IL296861A/en unknown
- 2021-03-31 CA CA3177186A patent/CA3177186A1/en active Pending
-
2022
- 2022-09-30 US US17/958,083 patent/US20230225985A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB2595355A (en) | 2021-11-24 |
| GB202215746D0 (en) | 2022-12-07 |
| US20230227390A1 (en) | 2023-07-20 |
| CN116194431B (zh) | 2026-01-02 |
| BR112022019616A2 (pt) | 2022-12-06 |
| MX2022011832A (es) | 2023-03-03 |
| WO2021198692A1 (en) | 2021-10-07 |
| JP7714571B2 (ja) | 2025-07-29 |
| GB2609814A (en) | 2023-02-15 |
| US12552733B2 (en) | 2026-02-17 |
| CA3177186A1 (en) | 2021-10-07 |
| US20230225985A1 (en) | 2023-07-20 |
| AU2021248627A1 (en) | 2022-12-01 |
| GB202104690D0 (en) | 2021-05-12 |
| IL296861A (en) | 2022-11-01 |
| EP4126800A1 (en) | 2023-02-08 |
| GB2609814B (en) | 2024-08-28 |
| JP2023520794A (ja) | 2023-05-19 |
| CN116194431A (zh) | 2023-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI451870B (zh) | 脂肪酸醯胺水解酶抑制劑 | |
| EP2760444B1 (de) | Cannabinoidcarbonsäuren, salze von cannabinoidcarbonsäuren, deren herstellung und anwendungen | |
| KR20230121808A (ko) | 약제학적 활성 화합물로서 칸나비노이드 유도체 및이의 제조 방법 | |
| Cannon et al. | Centrally acting emetics. 6. Derivatives of. beta.-naphthylamine and 2-indanamine | |
| US20240025858A1 (en) | Cannabinoid derivatives as pharmaceutically active compounds and method of preparation thereof | |
| KR20240007185A (ko) | 간질 치료를 위한 칸나비디올-c4의 유도체 | |
| JPH0684336B2 (ja) | 殺生物性芳香族化合物、その合成および医薬としてのその使用 | |
| KR20230121960A (ko) | 테르페노페놀 화합물 및 이의 용도 | |
| EP4190782A1 (en) | Biphenyl compound as immunomodulator, preparation method therefor and application thereof | |
| WO1995004028A1 (en) | Indane and tetrahydronaphthalene derivatives as calcium channel antagonists | |
| DE60121809T2 (de) | Materialien und verfahren zur herstellung von stilbenen | |
| Lipinski et al. | Bronchodilator and antiulcer phenoxypyrimidinones | |
| WO2008113565A1 (de) | Fluorsubstituierte amphetamine und amphetaminderivate und deren verwendung | |
| US7026516B2 (en) | Compounds with high monoamine transporter affinity | |
| US7691900B2 (en) | Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics | |
| FI77840C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara resorcinderivat. | |
| GB2628746A (en) | Terpenophenolic compounds and their use | |
| CN113521038A (zh) | 一种麻醉药物组合物及其应用 | |
| Venhuis et al. | Orally Active Analogues of the Dopaminergic Prodrug 6-(N, N-Di-n-propylamino)-3, 4, 5, 6, 7, 8-hexahydro-2 H-naphthalen-1-one: Synthesis and Pharmacological Activity | |
| JP2021505594A (ja) | 鎮痛化合物及びその製造方法 | |
| KR100398055B1 (ko) | 항산화 활성을 가지는 퀴논 화합물 | |
| JPH01186890A (ja) | シクロオクタン神経保護剤 | |
| KR101840178B1 (ko) | 〔２.２.２〕비시클릭 유도체 및 사용방법 | |
| Jordan | The synthesis of GdB-texaphyrins as novel multipurpose cancer drugs | |
| JPH0745475B2 (ja) | 複素多環式化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| D21 | Rejection of application intended |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11 | Administrative time limit extension requested |
Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |